Davide De Lucrezia

Vice President & General Manager at Officinae Bio

Contributing Author

Disclaimer: All opinions, ideas, and thoughts expressed and posted by Contributors at BiopharmaTrend.com platform are their own personal points of view, and do not represent neither Contributor's employers, nor BiopharmaTrend.com.

Latest articles from Davide

Why AI Needs to Be at the Center of mRNA Design

One of the biggest hurdles in mRNA development is the in vitro to in vivo gap; results that look strong in lab models often fail to translate in living systems. This gap arises not because the science is wrong, but …